Dattaguru Anandrao More

Title: Dattaguru Anandrao More: Innovator in Pharmaceutical Science

Introduction

Dattaguru Anandrao More, an accomplished inventor based in Kolhapur, India, has made notable contributions to the field of pharmaceutical science. With a keen focus on innovations that address critical health issues, he has successfully patented a compelling invention that highlights his expertise.

Latest Patents

Dattaguru holds a patent for "Fused pyrimidine derivatives as TRPV3 modulators." This invention relates to a series of fused pyrimidine derivatives that are beneficial for modulating Transient Receptor Potential Vanilloid 3 (TRPV3) receptors. The patented formula possesses potential in treating various diseases and disorders associated with TRPV3 modulation. The invention includes processes and pharmaceutically acceptable salts that enhance its applicability in medical treatments.

Career Highlights

Currently, Dattaguru is part of Glenmark Pharmaceuticals S.A., a leading company in the pharmaceutical sector. His work at Glenmark has enabled him to leverage advanced research and development methodologies to drive innovation in drug formulation and therapeutic approaches.

Collaborations

Throughout his career, Dattaguru has collaborated with notable individuals in the field, including V S Prasadarao Lingam and Abraham Thomas. These partnerships have fostered a collaborative environment that contributes to the rich exchange of ideas and advancements within the pharmaceutical industry.

Conclusion

With his innovative mindset and dedication to advancing medical science, Dattaguru Anandrao More stands out as a significant figure in the realm of pharmaceuticals. His patent, centered around TRPV3 modulation, exemplifies how innovative approaches can lead to breakthroughs in treating complex health conditions. As he continues his work at Glenmark Pharmaceuticals, the impact of his inventions is likely to resonate within the medical community and beyond.